Latest Breaking News On - Cell medx - Page 4 : comparemela.com

(1) Carson City, Nevada (Newsfile Corp. - May 26, 2021) - Cell MedX Corp. (OTCQB: CMXC) ( Cell MedX or the Company ), a biotech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general health and wellness, is pleased to announce that on May 25, 2021, the Company issued 2,484,500 common shares of the Company (the Shares ) on conversion of $496,900 the Company owed its debt holders under 6% demand notes payable and non-interest-bearing advances. In addition to issuance of the shares, the Debt holders agreed to forgive $32,677 in accrued interest. Concurrently with conversion of debt, the Company closed a non-brokered private placement financing at a price of $0.20 per Share, by issuing 200,000 Shares for total gross proceeds of $40,000.

United statesHoward isaacsFrank mcenultyRichard cavalliJim macfarlaneExchange commissionNevada newsfile corpCell medx corpCompany theCompany quarterlyBoard of directors cell medx corpCarson cityUnited states securities actCell medxGriffith armada capitalCurrent reports